2024 annual financial data
Capricor Therapeutics 2024 Operating margin
Capricor Therapeutics 2024 operating margin with verified reported values.
Direct answer
Operating margin was -191.13%.
Operating income was -42,564,842 USD and net income was -40,467,186 USD.
Operating cash flow was -39,995,742 USD.
Get free Capricor Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 22,270,465 USD
- Operating income
- -42,564,842 USD
- Net income
- -40,467,186 USD
- Operating cash flow
- -39,995,742 USD